Skip to content

Risk-reducing mastectomy and observational studies for cancer-free hereditary breast and ovarian cancer syndrome

Risk-reducing mastectomy and observational studies for cancer-free hereditary breast and ovarian cancer syndrome - Risk-reducing mastectomy and observational studies for cancer-free hereditary breast and ovarian cancer syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000042457
Enrollment
30
Registered
2021-02-01
Start date
2021-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hereditary breast and ovarian cancer syndrome

Interventions

Bilateral risk reducing mastectomy

Sponsors

Keio university
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: BRCA1 and 2 mutation carriers with breast and ovarian cancer-free cases who have received appropriate genetic counseling and have a good understanding of the disease and are willing to undergo bilateral risk reducing mastectomy.

Exclusion criteria

Exclusion criteria: A person who is judged by the principal investigator to be an inappropriate subject for this study.

Design outcomes

Primary

MeasureTime frame
prognosis

Countries

Japan

Contacts

Public ContactTomoko Seki

Keio university General and gastrointestinal surgery

tomnabe@z2.keio.jp0333531211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026